# FDA Inspection 1102280 - Baxter Corporation - September 17, 2019

Source: https://www.keypedia.com/records/fda_inspections/baxter-corporation/88a423b0-a56b-4ad6-9cc7-b7287886b885
Source feed: FDA_Inspections

> FDA Inspection 1102280 for Baxter Corporation on September 17, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102280
- Company Name: Baxter Corporation
- Inspection Date: 2019-09-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1259651 - 2025-01-31](https://www.keypedia.com/records/fda_inspections/baxter-corporation/37423882-4793-4df1-befc-f6f2a3fd88d1)
- [FDA Inspection 943637 - 2015-07-30](https://www.keypedia.com/records/fda_inspections/baxter-corporation/e91044a4-83b2-4b6f-ba92-b2ed87ca2375)
- [FDA Inspection 659975 - 2010-04-08](https://www.keypedia.com/records/fda_inspections/baxter-corporation/57c01e3a-ea83-40e9-87a1-b24aaebc8337)

Company: https://www.keypedia.com/companies/baxter-corporation/ca56a675-623d-4cdd-9810-05ae4ba274e0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c